Cognixion has announced a clinical trial that integrates its non-invasive EEG-based brain–computer interface (BCI) technology with the Apple Vision Pro with no surgery required. The aim of the trial ...
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, a pioneering brain–computer interface (BCI) company, today announced a clinical research project with Beth Israel ...
Precision Neuroscience has obtained an FDA clearance for a crucial piece of its plans for a full brain-computer interface system, starting with its minimally invasive cortical electrode array. The ...
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. AUSTIN, Texas--(BUSINESS ...
A review article just published on the state of clinical trials of implantable brain–computer interfaces (doi.org/njn8). Join the conversation. The global landscape ...
A review published in Advanced Science highlights the evolution of research related to implantable brain-computer interfaces (iBCIs), which decode brain signals that are then translated into commands ...
China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.
Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Layer 7 Cortical Interface — a high-resolution cortical electrode array for use in recording, monitoring, and stimulating ...
A series of converging advances in bio-implant technology, from brain-spine interfaces to lab-grown spinal tissue, is bringing the long-elusive goal of spinal cord repair closer to clinical reality.